RSV Antibody [RSHZ19 (Felvizumab) ], Rabbit IgG - Research Grade Biosimilar

• Other Statements:

  This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

• Reactivity:

  RSV

• Immunogen:

  This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework.

• Clonality:

  Recombinant Monoclonal

• Clone:

  RSHZ19 (Felvizumab)

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies, Biosimilars

• Field of Research:

  Infectious Disease, Other

• Concentration:

  Batch dependent

• Buffer:

  PBS with 0.02% Proclin 300.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.

• Fragment:

  IgG kappa

• Other Product Names:

  SB 209763, respiratory syncytial virus

• Tested Applications:

  Functional Assays, ELISA

• Species:

  Rabbit